Sfoglia per Soggetto "thromboembolism"
Items 1-20 di 32
-
20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation
(2018)Background: The accurate knowledge of secular trends in prevalence, characteristics and outcomes of patients with ischemic stroke and atrial fibrillation allows better projections into the future. Aim: We aimed to report ... -
Atrial high-rate episode duration thresholds and thromboembolic risk: A systematic review and meta-analysis
(2021)BACKGROUND: Available evidence supports an association between atrial high-rate episode (AHRE) burden and thromboembolic risk, but the necessary extent and duration of AHREs to increase the thromboembolic risk remain to ... -
“Blame it on the Comorbidities”: A 5-Year Follow-Up of 53 Chronic Dialysis-Dependent Patients Who Underwent Cardiac Surgery
(2016)Objectives This study evaluates midterm survival rates and risk factors for mortality of chronic dialysis-dependent patients undergoing cardiac surgery. Methods Fifty-three dialysis-dependent patients (34 males, aged 67 ± ... -
D-dimer as a diagnostic tool for canine thromboembolic disorders
(2010)D-dimers are small protein fragments present in the blood after a blood clot is degraded by plasmin. During the fibrin(ogen) degradation, a number of products are produced called fibrin(ogen) degradation products (FDPs). ... -
D-dimer as a diagnostic tool for canine thromboembolic disorders [Τα Δ-διμερή ως διαγνωστικό μέσο θρομβοεμβολικών διαταραχών στο σκύλο]
(2017)D-dimers are small protein fragments present in the blood after a blood clot is degraded by plasmin. During the fibrin(ogen) degradation, a number of products are produced called fibrin(ogen) degradation products (FDPs). ... -
Difficult situations in anticoagulation after stroke: Between Scylla and Charybdis
(2016)Purpose of review A significant proportion of stroke patients is treated with anticoagulants for secondary stroke prevention. Often, in such patients, stroke physicians are required to make difficult clinical decisions ... -
-
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies
(2022)Aims: Observational studies have investigated the effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) used in nonvalvular atrial fibrillation. We performed a systematic review ... -
Efficacy and Safety of Heparinization before Deployment of Endograft for Blunt Traumatic Aortic Injury in Severely Injured Patients
(2021)Background: The administration of unfractionated heparin (UFH) during endovascular repair of blunt traumatic aortic injury (BTAI) is controversial. The aim of the study is to report the early outcomes of patients undergoing ... -
Historical hallmarks of anticoagulation and antiplatelet agents
(2016)Thrombosis is a well known phenomenon among physicians since antiquity. A variety of peculiar agents, such as leeches and bark, were used to prevent it. Hirudin was used during the 19th century. The next eon, heparin, ... -
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
(2021)Background: The management of anticoagulation therapy around the time of catheter ablation (CA) procedure for adults with arrhythmia is critical and yet is variable in clinical practice. The ideal approach for safe and ... -
Introducing the “bleeding team”: Urgent reconstruction of an open fracture in a patient receiving acenocoumarol
(2021)Case: An elderly, polytrauma patient receiving vitamin K antagonist (VKA) for atrial fibrillation required immediate surgery for open distal tibial fracture. As the initial reversal with vitamin K and fresh frozen plasma ... -
The management of atrial fibrillation in heart failure: an expert panel consensus
(2021)Heart failure (HF) and atrial fibrillation (AF) often coexist, being closely interrelated as the one increases the prevalence and incidence and worsens the prognosis of the other. Their frequent coexistence raises several ... -
New prophylaxis strategies to reduce the risk of thromboembolism in cancer
(2021)Introduction: Patients with cancer are at risk of thrombotic events, mainly deep vein thrombosis and/or pulmonary embolism. The thrombosis risk is generally 4–6 times higher than in a healthy population and depends on ... -
Non-Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease
(2022)The prevention of atherothrombotic events is the primary goal in the treatment of patients with arteriosclerotic disorders. Despite recent improvements in the management of coronary artery disease (CAD) with revascularization ... -
Novel Clinical Concepts in Thrombosis: Integrated Care for Stroke Management-Easy as ABC
(2022)[No abstract available] -
Overestimation of the risk of revision with Kaplan-Meier presenting the long-term outcome of total hip replacement in older patients
(2018)Introduction: The purpose of the present study was (i) to review the long-term outcome of cemented Charnley total hip replacements (THRs) performed by 1 surgeon (GH), 20 to 42 years ago, in patients ≥60 years, using both ... -
Perioperative management of DOACs in vascular surgery: A practical approach
(2018)Background: Approximately 10–15% of patients on DOACs have to interrupt their anticoagulant before an invasive procedure every year. The perioperative management and monitoring of DOACs have proved to be challenging, as ... -
Persistent sciatic artery aneurysm: A potential cause of acute lower limb ischemia in young patients
(2017)[No abstract available]